Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial - Concepedia

Concepedia

Publication | Open Access

Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial

DOI Full Paper Access

37

Citations

7

References

2024

Year

Toni K. Choueiri, Konstantin Penkov, Hiroji Uemura, Matthew T. Campbell, Sumanta K. Pal, Christian Kollmannsberger, J.L. Lee, B. Venugopal, A.J.M. van den Eertwegh, Sylvie Négrier,

Annals of Oncology

References

	Year	Citations

Page 1